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KEY POINTS

 Stay up-to-date with federal, state, and local health authority regulations regarding elective procedures.
 Practices should err on the side of caution and continue rigorous screening protocols with additional safety measures for
the foreseeable future.
 Personal protective equipment should be escalated according to the transmission risk of SARS-CoV-2 during the
cosmetic/elective procedure.
 Utilization of televisits for cosmetic consults followed by a short in-person appointment to proceed with the treatment plan
may be useful even in the post-pandemic cosmetic practice.

INTRODUCTION
The COVID-19 pandemic has dramatically changed the
medical aesthetic practice. From impacting patient volume, to altering cosmetic trends, to necessitating reconfiguration of office protocols to promoting social
distancing, COVID-19 has unquestionably affected the
day-to-day experience for both providers and patients.
Although some of these changes are likely transient,
others may develop into long-term trends. This article
discusses pertinent studies on severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) transmission,
shares some helpful tips for managing a cosmetic practice during COVID-19, and gives an overview of some of
the current trends and guidelines that have emerged
during the pandemic.

THE SCIENCE BEHIND TRANSMISSION,
MASKS, AND VENTILATION
Transmission of Severe Acute Respiratory
Syndrome Coronavirus 2
SARS-CoV-2, the causative agent of COVID-19, is primarily transmitted through respiratory droplets and
aerosols (fine solid particles or liquid droplets suspended in air or another gas); however, other routes
of transmission, including body fluid routes, and
fecal-oral transmission, may rarely occur [1,2]. High
viral loads of SARS-CoV-2 have been detected in oral
fluids of both symptomatic and asymptomatic
COVID-19–positive patients [3,4], and speech and
other vocal activities, such as singing, have been shown
to generate aerosolized viral particles. The rate of
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emission of viral particles typically corresponds with
voice loudness, but a small fraction of individuals
behave as “speech superemitters,” who consistently
release an order of magnitude more particles than their
peers because of higher levels of surfactant in their
lungs [5]. Normal speaking produces thousands of
oral fluid droplets with a broad distribution of size
(1 mm to 500 mm). Whereas large droplets fall quickly
to the ground, small droplets can dehydrate and linger
as droplet nuclei (5 mm in diameter) in the air, where
they behave like an aerosol and expand the spatial
extent of emitted infectious particles [6]. These smaller
aerosolized particles are of particular concern because
they can remain airborne indefinitely under most indoor conditions unless they are removed by air currents or dilution ventilation. These small, aerosolized
particles can also be inhaled into the lowerrespiratory tract [7,8].
When aerosolized particles are inhaled, the virus is
introduced to the host. Although there are no hard
data showing exactly how many SARS-CoV-2 viral particles are needed for someone to become infected with
COVID-19, some have estimated it to be as low as 1000
particles. Theoretically, the risk of becoming infected is
therefore a combination of amount of virus someone is
exposed to and the time of that exposure. This combination would obviously vary significantly from individual
to individual. It is estimated that simple breathing releases roughly 20 viral particles a minute into the environment, so it would take roughly 50 minutes of an
unprotected encounter with an infected individual in
an enclosed space to reach the 1000 viral particles to
become infected. If someone is speaking, the number
of viral particles released increases roughly 10-fold to
about 200 particles per minute. That would decrease
the threshold exposure time down to about 5 minutes
in the same environment. If an infected individual is
shouting or singing, the release of viral particles is
even greater, and a cough or sneeze can release upwards
of 200,000 viral particles instantly [9]. It has also been
shown that greater viral loads are associated with lower
survival probabilities [10,11].
Given these findings, this transmission risk of SARSCoV-2 is especially high when people converse in
enclosed spaces with poor ventilation for extended periods of time [12]. One way to decrease this risk during
patient encounters is to limit speaking between patient
and providers especially during facial procedures that
require the removal of patient masks [13]. Other ways
to decrease transmission, such as proper mask wearing
and ventilation, are discussed later.

Masks and Respirators
There has been a significant amount of misinformation
regarding masks and respirators throughout the
pandemic, which is most likely due to a lack of understanding regarding the engineering of these products.
The filtering capacity of masks, respirators, and respirator cartridges is denoted by a letter and numeric value.
Filters are marked as either N, R, or P. The filters marked
N are not resistant to oil; R are somewhat resistant to
oil, and P are strongly resistant to oil. The number associated with each filter denotes its filtering capacity for
particles 0.3 mm in size. Hence, respirators with N95
filtering capacity are nonresistant to oil and can filter
out 95% of 0.3-mm particles [14].
SARS-CoV-2 is an enveloped virus with an approximate diameter of 0.1 mm. Although this is smaller than
0.3 mm, previous studies showed N95 respirators can filter w99.8% of viral particles with a diameter of 0.1 mm
[15]. The reason N95 respirators can successfully filter
these smaller viral particles is 2-fold. First, viral particles,
such as SARS-CoV-2, are often produced bonded with
biological materials, such as water or mucus; this larger
bonded particle is easily filtered by an N95 respirator.
Second, in addition to acting as a net that filters out particles greater than 0.3 mm, N95 respirator fibers can trap
very small particles via electrostatic attraction [16]. The
trapping of small molecules is facilitated by the random
motion patterns that such small particles exhibit (Brownian motion) [17]. It is important to note that reuse of
N95 respirators can lead to the dissipation of these electrostatic charges, hence reducing the filtering capacity of
the respirators with prolonged use.
Although N95 respirators are the ideal face covering
for both self-protection and protecting close contacts,
cloth and surgical masks can also be effective in
decreasing transmission. Although cloth and surgical
masks are primarily protective against droplet particles
(>5 mm), evidence suggests they may reduce viral aerosol shedding and thus help with source control [18,19].
Generally available household materials have a filtration rate between 49% and 86% for exhaled particles
0.02 mm in size, whereas surgical masks have a filtration
rate between 75% and 89% for the same sized particles
[20,21]. Using laser-light scattering, a recent study
demonstrated that virtually no droplets were “expelled”
with a homemade mask consisting of a washcloth
attached with 2 rubber bands around the head. The
same study demonstrated significant viral levels were
expelled without a mask [22]. It was estimated that if
at least 60% of the population wore masks that were
60% effective in blocking viral transmission (eg, a
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well-fitting, 2-layer cotton mask), the epidemic could
be significantly mitigated [23,24]. Therefore, both patients and providers should at a very minimum wear a
surgical mask or a cloth mask at all times. Given patients may arrive with poorly sealed masks or homemade masks with variable filtering capacities, it may
be ideal to provide patients with new surgical masks
before check-in to wear during their appointment.

Ventilation
The Centers for Disease Control and Prevention (CDC)
recently posted guidelines stressing the importance of
improving ventilation in office buildings. The recommendations included the following: (1) increasing the
percentage of outdoor air (eg, using economizer modes
of heating, ventilation, and air conditioning operations) potentially as high as 100%; (2) considering using natural ventilation (eg, opening windows if possible
and safe to do) to increase outdoor air dilution; (3)
increasing air filtration to high as possible (minimum
efficiency reporting value 13 or 14); and (4) considering
using portable high-efficiency particulate air [HEPA]
fan/filtration systems to enhance air cleaning, especially
in higher-risk areas [25,26]. A low-cost air purifier with
a HEPA system costs approximately $100, can circulate
air in a 155-square-foot room 5 times per hour, and can
be easily widely deployed though clinic spaces [27].
The importance of natural ventilation is exemplified
by a recent investigation of SARS-CoV-2 transmission
among bus riders in Eastern China in January 2020.
This cohort study examined a community of 128 lay
Buddhists from the Zhejiang province who took 2 buses
(60 on bus 1 and 68 on bus 2) on a 100-minute trip to
attend a 150-minute worship event. The source patient
was a passenger on bus 2. In both buses, central air conditioners were in indoor recirculation mode. Not surprisingly, 24 of the 68 individuals on bus 2 were later
diagnosed with SARS-CoV-2 infection, whereas none
of the 60 individuals in bus 1 were infected. Passengers
sitting closer to the index case did not have a statistically
significant higher risk of COVID-19 than those sitting
farther away. However, all passengers sitting close to a
window remained healthy, with the exception of the
passenger sitting next to the index case [28].
Recirculation of indoor air is not thought to be sufficient to decrease transmission, as demonstrated by
an outbreak at a training workshop in Hangzhou city,
Zhejiang province. Thirty attendees from different cities
attended the workshop, which consisted of four 4-hour
group sessions in 2 closed rooms of 49 m2 and 75 m2.
An automatic timer on the central air conditioners
circulated the air in each room for 10 minutes every
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4 hours using “an indoor recirculating mode.” Although
none of the workshop participants were symptomatic
during the workshop, 15 of them were diagnosed
with SARS-CoV-2 infection shortly after the conclusion
of the workshop [29].

Upper Room Disinfection Using UV-C
During the COVID-19 pandemic, UV-C has gained significant popularity as a method of disinfection against
SARS-CoV-2. Briefly, UV-C (254 nm) photons are
absorbed by microbial nucleic acids, leading to the formation of cyclobutane pyrimidine dimers and the
release of reactive oxygen species, which damage the microbial DNA, preventing replication and inactivating
the microorganism [30]. Nardell and Nathavitharana
[31] made the argument that upper-room disinfection
by UV-C coupled with adequate ventilation can significantly reduce the risk of contracting COVID-19. In line
with this, the CDC stated in their recent guidelines that
UV germicidal irradiation (UVGI) could be considered a
supplement to help inactivate the virus [25]. When used
correctly, UVGI can be performed without an increase
in the incidence of UV-C overexposure side effects,
such as eye and skin irritation [32–35].
In addition to being used in public and high-traffic
areas, upper-room UVGI may be used to reduce risk
of viral plume during certain laser procedures. The fixtures are typically mounted at least 7 feet above the
ground, with at least 1 foot of space above the fixture
for decontamination to occur. Upper-room UVGI is
typically recommended when ventilation rates are
low, because when ventilation rates are greater than 6
air changes per hour, it may be less effective in comparison to particle removal by ventilation because particles
may have less residence exposure time to UV-C [35].

OFFICE PROTOCOLS AND GUIDELINES IN
THE COVID-19 ERA
Screening of Patients and Health Care
Personnel
Screening measures and protocols will continue to
evolve as community prevalence of COVID-19 changes.
Screening has become ubiquitous in the pandemic era
(Fig. 1 provides an example of a screening protocol),
and although current screening methods are able to
detect symptomatic and high-risk individuals, it still remains an imperfect barrier to spread [36]. Mathematical
models have demonstrated that screening misses
approximately half of the infections in a growing
pandemic because of the high percentage of newly
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Prescreening ques onnaire administered
at me of appointment booking

ab

Pa ent with symptoms concerning for
COVID-19, recent exposure, or recent
travel to area with high rate of
community transmission

Do not book appointment for cosme c
treatment for at least 14 d. Advise
pa ent to speak with primary care
provider if symptoma c

No concerning
symptoms, recent
exposure, or recent
travel

Book appointment and inform pa ent of
new oﬃce protocols in place for COVID-19
Op onal step: Addi onal
prescreening ques onnaire
administered 24-48 h
prior to appointment

Day of appointment: pa ent arrives, and
screening ques onnaire again
administered.c Consider temperature
monitoring with a no-touch thermometer
in areas with high rate of community
spread

Pa ent with symptoms concerning for
COVID-19, recent exposure, or
temperature >100.4°F

Pa ent is asymptoma c, afebrile, and
with no close contacts of conﬁrmed
COVID-19

Pa ent should be sent home to self-isolate
and should contact their primary care
physician.
Pa ent was
screened and sent
home prior to
entering clinic

Pa ent entered
clinic prior to
screening and
iden ﬁca on of
possible infec on

Disinfect all clinic areas
pa ent visited

Nothing more
needs to be done

Pa ent proceeds to wai ng room or
treatment room for appointment

Postvisit follow-up to monitor for recently
developed COVID-19 symptoms

FIG. 1 Patient screening protocol for a cosmetic outpatient practice. a For elective aesthetic surgical
procedures, the ASPS recommends preoperative reverse transcription polymerase chain reaction testing for
acute infection when available. This should be scheduled at the time of patient booking. b Screening
questionnaires should be tailored to current CDC guidelines and should focus on symptoms, travel history,
and recent sick contacts. c Ideally, in-person screening stations should be set up outside the clinic or in a
contained area designated for screening to minimize interactions before clearance.

exposed asymptomatic patients still in the incubation
period. In addition, the sensitivity of thermal scanners
[37] and lack of truthful self-reporting on screening
questionnaires can decrease the ability of screening protocols to detect cases [38]. Despite these faults,
screening questionnaires and noncontact thermal scanners (Fig. 2) can detect a proportion of active infections,
and as the pandemic decelerates and there are less
newly exposed individuals, screening should become
more sensitive. Therefore, especially in the cosmetic
setting whereby procedures are elective, practices
should err on the side of caution and continue with
rigorous screening protocols in parallel with additional
safety measures for the foreseeable future.
Regarding staff screening, the Aesthetic Society
COVID-19 Safety Task Force [39] recommends all staff
members have their temperatures taken and recorded
at the start of the day. A short questionnaire should
also be administered to staff daily requiring self-

attestation that they are asymptomatic and unaware of
any sick contacts [40]. Staff should be reminded
frequently that sick-leave policies are flexible and to
not report to work if they even think they may be symptomatic. Although in the past some offices may have set
up a culture in which it was acceptable to work through
a cold, today this cannot happen, and all efforts must be
made to encourage staff to stay at home if they have
even the slightest symptoms.

Appointment Scheduling
Scheduling templates should be adjusted to minimize
appointment lengths. Although the exact duration of
exposure needed for transmission is unknown, brief interactions (<15 minutes) are less likely to result in transmission [41], and thus, appointment times should be
scheduled for 10 minutes or less. Shortened appointment times should be discussed at the time of booking
to help manage expectations and minimize
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FIG. 2 Noncontact thermal scanners.

dissatisfaction. Patients should be encouraged to visit
the clinic alone to avoid crowding in examination
rooms [42]. Utilization of televisits for cosmetic consults followed by a short in-person appointment to proceed with the treatment plan can help minimize
provider-patient interaction times and may be useful
even in the postpandemic cosmetic practice.
In addition, scheduling templates should be
adjusted to prolong the time in between patient visits.
Longer periods of time between patient visits help to
minimize the number of patients in an office at a given
time and provides staff with sufficient time to clean
the clinic rooms between patients. Although fomite
transmission is not thought to be the main way SARSCoV-2 spreads [43], an elevated level of cleaning and
sanitization between patients should continue until
further definitive data are acquired.

Avoidance of Waiting Rooms
The use of waiting rooms should be minimized in the
era of COVID-19. This can be accomplished through
implementation of new patient arrival protocols and
through physical reconfiguration of waiting rooms
(Figs. 3 and 4). Chairs should be spaced at least 6 feet
apart, and touch points, such as reading materials, sample stations, and food/drink, should be removed
[39,40]. Placing large stickers on floors spaced 6 feet
apart can serve as a gentle reminder to patients to socially distance at check-in and checkout areas.
Patients should be instructed not to arrive more than
5 or 10 minutes before their appointments. Other measures, such as having the patient wait in their vehicle until a staff member is ready to receive and room them,
can also be implemented. Online patient portals and
e-communication for registration and paperwork
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FIG. 3 Reconfiguration of waiting room to promote social distancing and minimize contact.

should be used to minimize patient contact. Furthermore, plastic/acrylic windows panels or glass partitions,
especially in waiting rooms, should be used whenever
possible to decrease staff and health care personnel
(HCP) exposure [44].
With time, a slow transition to normalcy may be
possible, but this transition should be gradual given
the high-risk nature of waiting rooms (multiple potentially sick patients congregating in a small space with
multiple touch points). Furthermore, consent forms
for treatment may need to be modified to clearly state
that there may be increased risks of acquiring SARSCoV-2/COVID-19 in close proximity to doctors, nurses,
or other patients, and that the patients understand these
risks in relation to seeking any type of medical care in
the COVID-19 era.

Social Distancing
The CDC recommends maintaining at least 6 feet of distance from others [45], and although unfeasible for
practitioners and patients during cosmetic treatments,
this rule should be implemented at all other times during a patient visit, including during check-in, during
checkout, and in the elevators (Fig. 5). A systematic review and meta-analysis (that included data for SARSCoV-2, SARS-CoV, and Middle East Respiratory Syndrome Coronavirus [MERS-CoV] found that transmission of viruses was lower with physical distancing of
1 m or more, compared with a distance of less than
1 m (n 5 10,736, pooled adjusted odds ratio [aOR]
0.18, 95% confidence interval [CI] 0.09 to 0.38; risk difference [RD] 10.2%, 95% CI 11.5 to 7.5; moderate
certainty); protection was increased as distance was
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Pa ent calls or texts clinic upon arrival but
prior to entering clinic (pa ent can wait in
car or outdoors)

Staﬀ receives no ﬁca on pa ent has
arrived. When the provider is ready to see
the pa ent, a staﬀ member contacts
pa ent

Wellness check, and hand hygiene
performed (ideally outside clinic or in
designated screening loca on). Staﬀ
ensures pa ent is wearing adequate face
covering

Staﬀ member escorts pa ent directly to
clinic room, thereby bypassing wai ng
room
FIG. 4 A patient arrival protocol that bypasses the need for
waiting rooms.

lengthened (change in relative risk [RR] 2.02 per meter;
pinteraction 5 0$041; moderate certainty) [19]. There are
currently no studies showing a beneficial effect of using
larger examination rooms during patient encounters.
However, use of larger rooms could be considered, if
available, to help promote social distancing during portions of the patient visit that do not require close contact between the provider and the patient, such as
initial history taking and patient education.

115

AN EXPOSURE OCCURS AT WORK—NOW
WHAT?
What Is Classified as “an Exposure”?
Per CDC guidelines, an exposure in the health care setting
is classified as an HCP who has prolongeda (15 minutes)
close contact (<6 feet) with a COVID-19–positive person
(either laboratory confirmed or clinically compatible)
from 2 days before symptom onset until the infected person meets criteria for discontinuing home isolation [46].b

What Are the Work Restrictions and
Quarantine Requirements for Asymptomatic
Health Care Personnel with Severe Acute
Respiratory Syndrome Coronavirus 2
Exposure?
Fourteen-day self-isolation and work restrictions are only
required if both (1) an exposure occurs as defined above
AND (2) the HCP was unprotected during the exposure
(ie, HCP was not wearing a respirator or face mask, or the
HCP was not wearing eye protection if the person with
COVID-19 was not wearing a face mask) [46]. If, however, an exposure occurs and the HCP was protected (HCP
wearing appropriate personal protective equipment
[PPE] AND the infected individual was wearing a face
mask), the CDC states that the HCP can continue work
without need for quarantine or testing.

Should the Exposed Health Care Personnel
Be Tested for COVID-19? Can Postexposure
Testing Be Used to Allow Health Care
Personnel to Return to Work Before 14 Days?
There are no set guidelines for postexposure testing in
the health care setting. The CDC recommends considering testing an exposed, unprotected HCP using authorized nucleic acid or antigen detection assays if testing is
readily available and result turnaround time is less than
24 hours [47]. However, the CDC recommends caution
with using postexposure testing to allow an unprotected
exposed HCP to return to work before 14 days given the
potential for false negative results early in the disease
course; if testing is pursued and the initial test is negative, repeat testing should be considered (Fig. 6).
a

Any duration of exposure should be considered prolonged if
the exposure occurred during an AGP.
b

For mild to moderate illness in nonimmunocompromised
patients with COVID-19, home isolation should be
continued, and people should not return to work until (1)
at least 10 days have passed since symptom onset; and (2)
at least 24 hours have passed since last fever without the use
of fever-reducing medications; and (3) symptoms have
improved.
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FIG. 5 Social distancing in elevators.

A Health Care Worker Develops a Fever and
Cough—What Next?
If an HCP develops even mild symptoms consistent
with COVID-19, they must cease patient care, notify
their supervisor, leave work immediately, and selfisolate. These individuals should be prioritized for
testing and should not return to work until they meet
criteria for discontinuing home isolation [46] (see
Fig. 6 for additional guidance).

PRECAUTIONS RELATED TO SPECIFIC
COSMETIC PROCEDURES AND BODY SITE
Risk Stratification of Procedures
Kapoor and colleagues [42] classified various aesthetic
procedures as low risk, moderate risk, and high risk

based on the likelihood of transmission of SARS-CoV2 from the patient to the treating HCP during the procedure. The risk stratification was based on the type of
procedure being performed (aerosol-generating procedure [AGP] vs non-aerosol-generating procedure), body
part on which the procedure is being performed (face/
body), and the duration of the procedure. Additional
considerations included contact with mucosa/saliva,
body secretions during the procedure, and the ability
of the patient to remain masked. Low-risk aesthetic
procedures included injectables for the upper third of
the face and extrafacial sites, injection lipolysis on extrafacial sites, cryolipolysis on the body, nonablative fractional resurfacing lasers for extrafacial sites, highintensity focused ultrasound for extrafacial parts,
radiofrequency tightening (RF) for extrafacial areas,
platelet-rich plasma (PRP) therapy for scalp or body
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Exposure occurs (health care personnel had
prolonged (≥15 min) close contact (<6
feet) with COVID- 19-infected person)

HCP symptoma c

Immediately contact supervisor, leave work,
and self-isolate

HCP asymptoma c

HCP and sick contact were
wearing appropriate PPE

1.
2.

•
•

No work
restric ons
Con nue to selfmonitor for
symptoms

3.

•

•
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HCP was not wearing a
facemask or
Infected individual not
wearing facemask and
HCP not wearing eye
protec on or
HCP not wearing all
recommended PPE
(gown, gloves, eye
protec on, respiratory)
while performing an
aerosol-genera ng
procedure

Priori ze tes ng with authorized nucleic acid
or an gen detec on assay

SARS-CoV-2
nega ve

Consider repeat
tes ng

HCP should isolate and
not a end work for 14
d
Could consider tes ng
in areas where tes ng
is readily available and
turnaround me is less
than 24 h

SARS-CoV-2
posi ve

•
•

Alert all close contacts from 2 d before symptom onset
Symptoms-based strategy for return to work preferred.
HCP with mild to moderate illness who are non
immunocompromised should isolate and not return to
work un l:
1. At least 10 days have passed since symptom
onset AND
2. At least 24 h have passed since last fever
without the use of fever-reducing medica ons
AND
3. Symptoms have improved

Tes ng pursued

SARS-CoV-2 posi ve
(HCP s ll
asymptoma c)

Test-based strategy for return to
work needed. HCP needs 2
nega ve consecu ve tests prior
to returning to work

FIG. 6 Guidance for (1) HCP exposed to SARS-CoV-2 and (2) symptomatic HCP. (Data from Centers for
Disease Control and Prevention. Information for Healthcare Professionals about Coronavirus (COVID-19).
https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html. Accessed August 22, 2020.)

areas, laser hair removal (LHR) of upper face and body
areas with contact cooling device, low-level light therapy, chemical peels, body treatments with electronic
muscle stimulator, intravenous injection therapy,
sclerotherapy, and hydrafacial [42].
Moderate-risk aesthetic procedures included microneedling procedures (with or without RF) on the face
and extrafacial sites, thread lifting on the face and
extrafacial sites, invasive RF devices for face and extrafacial sites, soft tissue fillers in the lips, soft tissue
fillers/PRP in the genital areas, and RF/lasers for genital area [42].
High-risk procedures included AGPs or plumeproducing procedures, such as Q-switched Nd:YAG, alexandrite, ruby lasers, pulse-dye laser, ablative resurfacing
lasers (fractional and nonfractional), LHR with noncontact cooling devices (generating plume), electrofulguration, electrocautery, microdermabrasion, jet infusions/
facials, DermaJet devices, micropigmentation, microblading, and body treatments with plasma devices [42].
For all tiers, at the very minimum, disposable gloves
and surgical masks should be worn. Although direct evidence is minimal, eye protection at all times is also recommended. During high-risk procedures, face shields

should be used, and finally, during moderate- to highrisk procedures, an N95 respirator should be worn
underneath a surgical mask [42]. See additional considerations based on body location and procedure in later
discussion.

Head and Neck Procedures
Given procedures on the head and neck may be associated with increased risk of contracting SARS-CoV-2
compared with procedures below the clavicle [48], additional protective measures should be considered, such as
the following: (1) elevating PPE to include N95 respirators and face shields [39,48]; (2) not having the patient
speak while their mask is off to minimize risk of airborne
transmission [6]; (3) keeping appointment times to a
minimum (preferably under 10 minutes); and (4) using
larger rooms given the size of a procedure room may influence risk of contracting COVID-19 [48].
The conjunctiva of the eye is easily exposed to infectious droplets and fomites during close contact with
infected individuals and contaminated hands. A recent
systematic review and meta-analysis (that included data
for SARS-CoV-2, SARS-CoV, and MERS) found that eye
protection was associated with lower infection
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(n 5 3713; aOR 0.22, 95% CI 0.12–0$39, RD 10.6%,
95% CI 12.5 to 7.7; low certainty) [19]. Some respiratory viruses, such as human adenovirus and avian influenza virus (H7), frequently cause highly infectious
conjunctivitis or keratoconjunctivitis. Hence, the conjunctiva is proposed to be an important portal of entry for respiratory viruses, and tear and conjunctival secretions may
contain virus and spread viral infection [49,50]. Therefore, when working close to the face of a patient, wearing
protective eyewear should be implemented.

Trunk and Extremity Procedures
Body-contouring procedures on the trunk and extremities, such as cryolipolysis, RF, and electromagnetic energy treatments, have the advantages of limited need
for face-to-face contact between the provider and the
patient, and no need for the patient to remove their
mask during treatment. These procedures however
often require lengthy appointments, so limited inroom contact with the patient once the treatment has
begun and strict enforcement of mask wearing
throughout the entire procedure (even when alone in
a treatment room) will help reduce transmission risk.

Injectables
Procedures such as neurotoxin and dermal filler injections create exposure risk because of the close contact
required between the provider and the patient, and the
potential need for patient mask removal [40]. Injectable
procedures involving the oral cavity or nose, such as central face filler, may be classified as AGPs, and appropriate
elevation of PPE as described above should be used [51].
Although neurotoxin injections can typically be performed in less than 10 minutes, filler treatments to multiple areas may take longer, and a staged approach
should be considered. Having the patient rinse their
mouth with 0.5% hydrogen peroxide or 1% povidoneiodine immediately before procedures such as lip injections with soft tissue fillers may be considered [42,52].

SARS-CoV-2 has been identified in both blood and
skin of infected individuals [55,56]; although no
studies have directly looked at SARS-CoV-2 transmission in relation to laser treatments, there is a theoretic
risk. Use of plume evacuation systems with filters that
remove particulates as small as 0.1 mm, known as an ultralow particular air filter, may be considered [57].
It is uncertain if forced air-cooling increases risk of
contracting COVID-19. During January 26 to February
10, 2020, an outbreak of 2019 novel coronavirus disease in an air-conditioned restaurant in Guangzhou,
China involved 3 family clusters. Virus transmission
in this outbreak could not be explained by droplet
transmission alone. However, strong airflow from the
air conditioner could have propagated droplets from table C to table A, then to table B, and then back to table
C. Thus, the airflow direction prompted by the airconditioned ventilation was consistent with droplet
transmission [58]. Therefore, given the positive pressure
nature of forced air-cooling devices, alternative pain
control techniques during laser- and light-based treatments should be used [40,48].
Clinics should ensure protocols for adequate sanitization of laser tips, handpieces, and goggles between
patients. For LHR, patients should be asked to shave
at home before coming to the procedure to reduce contact time with staff [42].

Electrosurgery
Similar to laser- and light-based devices, plumes can be
generated by electrosurgical procedures. Electrosurgery
may be classified as nonrespiratory AGPs, and necessary
precautions should be taken [59].

Microneedling, Microdermabrasion,
Dermaplaning, Chemical Peels
Although these procedures may be performed outside a
physician’s office, they still necessitate adequate PPE
given they are often performed in the perioral region
and require prolonged patient contact time.

Laser and Energy-Based Treatments
Caution should also be used during laser- and energybased treatments because in addition to close contact
and frequent need for patient mask removal, laserand light-based devices can be classified as nonrespiratory AGPs owing to plumes containing aerosolized
particles of blood and skin [53]. It has been demonstrated that thermal disruption of viable human cells results in the release of carbon particles, virus, bacteria,
DNA, and toxic gases in all surgical plume with the
exception of lower-powered lasers [54]. Although very
uncommon, especially in asymptomatic patients,

PATIENT VOLUME AND AESTHETIC
TRENDS
During the height of the pandemic, many elective procedures were postponed, and some aesthetic-based practices were temporarily closed. Consequently, it is no
surprise that the American Society of Plastic Surgeons
(ASPS) anticipates a decrease in total number of cosmetic
procedures in 2020 because of COVID-19. In addition to
a decrease in number of procedures performed, patient
interest waned as demonstrated by a recent analysis of
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Google Trends, which showed a decrease in online
searches for cosmetic procedures, such as “lip fillers”
and “Botox,” during March and April 2020. More
recently, however, these searches have begun to increase
and are now nearing pre–COVID-19 levels [60]. In addition, a recent national survey of more than 1000 people
conducted by the ASPS showed that despite the COVID19 pandemic, 49% of those who have not had plastic
surgery previously would be open to cosmetic or reconstructive treatment in the future [61].
In the COVID-19 era, there appears to be a growing
trend toward more minimally invasive cosmetic procedures that allow for minimal contact time and follow-up
in health care facilities. According to the ASPS, of the
most-requested treatments during telemedicine appointments, 65% were for botulinum toxin type A
fillers (eg, Botox, Dysport, and Xeomin), and 37%
were for soft tissue fillers (eg, Juvéderm, Radiesse, Restylane, Sculptra, and Belotero). Lip injections were still
popular despite mandates for mask wearing in public
[62], which may be explained by less patient concern
with postprocedure erythema and bruising given mask
wearing and cancellation of many social gatherings. In
addition, the authors have anecdotally noticed an
increasing number of patients who seek cosmetic intervention to improve their appearance on Zoom. This
concern is reflected by Zoom’s “Touch Up My Appearance” feature on its video conferencing service, which
allows users to create “a softening effect to skin to minimize the visibility of imperfections” [62].

SUMMARY
Cosmetic clinical protocols, guidelines, and trends will
undoubtedly continue to evolve based on COVID-19
community prevalence, transmission rates, and
emerging scientific evidence. Although even stringent
office protocols and safety measures are imperfect, erring on the side of caution and staying up-to-date with
federal, state, and local health authority regulations
regarding elective medical procedures can increase
safety for both aesthetic patients and providers.

CLINICS CARE POINTS



Patients, providers, and staff should wear a surgical or
cloth mask at all times.



Limit speaking between patient and providers particularly during facial procedures that require the
removal of patient masks.
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The use of waiting rooms should be minimized in the
era of COVID-19.



Scheduling templates should be adjusted to minimize
appointment lengths.



The Centers for Disease Control and Prevention
recently posted guidelines stressing the importance
of improving ventilation in office buildings.



All efforts must be made to encourage staff to stay at
home if they have even the slightest symptoms.



During moderate- to high-risk procedures, an N95
respirator should be worn underneath a surgical
mask. During high-risk procedures, face shields
should also be used.



Especially in the cosmetic setting, where procedures
are elective, practices should err on the side of
caution and continue with rigorous screening protocols in parallel with additional safety measures for the
foreseeable future.
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